AbbVie launched a revamped version of its Allē loyalty program, which ultimately was not adopted by providers. The marketing ...
US drugmaker AbbVie has agreed to buy struggling ... our focus on innovative science.” Allergan CEO Brent Saunders, who claims a seat on the new company’s board, said the deal will create ...
Allergan has an attractive portfolio of beauty drugs, including Botox, which now belong to AbbVie. The combined company will have product lines spanning immunology, hematologic oncology ...
Allergan has confirmed that it will divest experimental inflammatory bowel disease therapy brazikumab and marketed drug Zenpep ahead of its $63 billion acquisition by AbbVie. The company announced ...
4 biotechs that could be the next takeout targets after AbbVie's $63 billion acquisition of Allergan
US drugmaker AbbVie just announced a mega-deal to buy pharmaceutical company Allergan for about $63 billion. With Tuesday's deal, AbbVie is betting on Allergan cosmetic products like the well ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback